Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 2 Thrombocythemia, Essential 1 Stomach Neoplasms 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Patient Outcome Assessment 1 Pancreatic Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia 1 Gastrointestinal Neoplasms 1 ESCC 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Anemia, Refractory, with Excess of Blasts 1 Adenocarcinoma 1

Interventions

Gemcitabine 358 Fluorouracil 94 Oxaliplatin 81 Capecitabine 74 130-nm albumin-bound paclitaxel 71 Albumin-Bound Paclitaxel 70 Radiotherapy 67 Leucovorin 58 Irinotecan 49 Erlotinib Hydrochloride 47 Cisplatin 44 Bevacizumab 31 pembrolizumab 30 Radiosurgery 30 Docetaxel 26 Taxes 24 Nivolumab 24 Cetuximab 24 Pancreaticoduodenectomy 20 Drug Therapy 17 folfirinox 16 Cyclophosphamide 16 Radiation 15 Ipilimumab 13 Endoscopic Ultrasound-Guided Fine Needle Aspiration 13 Surgical Procedures, Operative 12 Sorafenib 12 Paclitaxel 12 Neoadjuvant Therapy 12 irinotecan sucrosofate 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Pancreatic Neoplasms × Induction Chemotherapy × Clear all

NCT01827553 2024-04-11

CONKO-007

University of Erlangen-Nürnberg Medical School

Phase 3 Completed

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡